Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
PreciseDx
PreciseDx is a pioneering company in cancer risk stratification, utilizing its proprietary AI platform, OncoIntelligence™, to provide rapid and accurate patient-specific risk assessments for breast…
PreciseDx
PreciseDx is a pioneering company in cancer risk stratification, utilizing its proprietary AI platform, OncoIntelligence™, to provide rapid and accurate patient-specific risk assessments for breast…
TL;DR
Product: PreciseBreast — AI-driven, morphology-based breast cancer risk-of-recurrence test
Platform: OncoIntelligence (Morphology Feature Array)
Clinical validation: Validated in >3,000 cases (company reports)
Funding: Series B announced June 5, 2025; recent $11M close led by Eventide
Regulatory / lab status: CLIA and New York State DOH assay validation reported
Company Overview
Problem Domain
Oncology diagnostics; cancer risk stratification for breast cancer
Founded
2019
Industry
Biotechnology
Tech Stack
Funding Track Record
Series B announced June 5, 2025; company announced an $11M close led by Eventide on June 18, 2025 with participation from other strategic investors.
Investor Signal
“Participation from strategic diagnostics and healthcare investors including LabCorp, Quest Diagnostics, Merck Global Health Innovation Fund, Philips Health Technology Ventures, Agilent Technologies, IBM Ventures, Mount Sinai Health System”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
60,000+
Open Roles
200+
New This Week